Funding for Connecticut's Drug Database to End This Year
Funding for Connecticut's drug monitoring database is expected to run out this fall, according to a Connecticut Mirror report.
The database, which costs about $200,000 a year to maintain, began operations in 2008 and is funded through federal grant money and settlements with pharmaceutical companies. The system requires a program manager and a vendor contract for the database that holds prescription information.
"We'd be in a lot of trouble without it," said David Kloth, MD, past president and executive director of the Connecticut Pain Society and a pain management specialist who practices in Danbury and Waterbury. "It is absolutely an essential part of managing pain patients today. The incidence of drug abuse in this country is epidemic."
Related Articles on Pain Management:
Kentucky Physician: Prescription Drug Legislation Must Not Ignore Patients in PainDr. Matthew Rupert First Tennessee Physician to Implant 16 Percutaneous Lead
Study Reinforces Effectiveness of Cooled Radiofrequency Treatment
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
Latest Articles
- House Votes to Repeal the PPACA — for 37th Time
- 6 Statistics on Concierge and Direct Pay Physician Practices
- Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
- 5 Things to Know About Medical Office Visits in 2012
- Medical Facilities Corporation Reports Higher Revenue After Arkansas Surgical Hospital Acquisition